$350 | Single User
$700 | Site License
$1050 | Enterprise License

Biotechnology in Asia-Pacific
[Lowest Price Guaranteed: $350]

Published by Marketline: 17 Dec 2019 | 260962 | In Stock
Related Topics: Biotechnology

Introduction

Biotechnology in Asia-Pacific

Summary

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

- The Asia-Pacific biotechnology industry had total revenues of .5bn in 2018, representing a compound annual growth rate (CAGR) of 6.3% between 2014 and 2018.

- The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of .8bn, equivalent to 54.1% of the industry's overall value.

- The industry is driven mainly by Japan and China, which accounted for 37.6% and 20.9% of its total value in 2018.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the Asia-Pacific biotechnology market by value in 2018?

- What will be the size of the Asia-Pacific biotechnology market in 2023?

- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Asia-Pacific's biotechnology market?

Table of Contents
for Biotechnology in Asia-Pacific

  • Table of Contents

    1 Executive Summary

    1.1. Market value

    1.2. Market value forecast

    1.3. Category segmentation

    1.4. Geography segmentation

    1.5. Market rivalry

    1.6. Competitive Landscape

    2 Market Overview

    2.1. Market definition

    2.2. Market analysis

    3 Market Data

    3.1. Market value

    4 Market Segmentation

    4.1. Category segmentation

    4.2. Geography segmentation

    5 Market Outlook

    5.1. Market value forecast

    6 Five Forces Analysis

    6.1. Summary

    6.2. Buyer power

    6.3. Supplier power

    6.4. New entrants

    6.5. Threat of substitutes

    6.6. Degree of rivalry

    7 Competitive Landscape

    7.1. Who are the leading players in the market?

    7.2. What strategies do leading players follow?

    7.3. What are the strengths of leading players?

    7.4. What has been the rationale behind recent M&A activity?

    7.5. Have there been any new product launches in recent years?

    7.6. What are the weaknesses of leading players?

    8 Company Profiles

    8.1. Shanghai Kehua Bio-engineering Co Ltd

    8.2. Astellas Pharma China Inc

    8.3. Novo Nordisk Pharmatech A/S

    8.4. Takeda Pharmaceutical Company Limited

    9 Appendix

    9.1. Methodology

    9.2. About MarketLine

List Of Tables
in Biotechnology in Asia-Pacific

List of Tables

Table 1: Asia-Pacific biotechnology industry value: $ million, 2014-18

Table 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2018

Table 3: Asia-Pacific biotechnology industry geography segmentation: $ million, 2018

Table 4: Asia-Pacific biotechnology industry value forecast: $ million, 2018-23

Table 5: Shanghai Kehua Bio-engineering Co Ltd: key facts

Table 6: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios

Table 7: Shanghai Kehua Bio-engineering Co Ltd: Key Employees

Table 8: Astellas Pharma China Inc: key facts

Table 9: Astellas Pharma China Inc: Key Employees

Table 10: Novo Nordisk Pharmatech A/S: key facts

Table 11: Novo Nordisk Pharmatech A/S: Key Employees

Table 12: Takeda Pharmaceutical Company Limited: key facts

Table 13: Takeda Pharmaceutical Company Limited: Annual Financial Ratios

Table 14: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)

Table 15: Takeda Pharmaceutical Company Limited: Key Employees

Table 16: Takeda Pharmaceutical Company Limited: Key Employees Continued

List Of Figures, Charts and Diagrams
in Biotechnology in Asia-Pacific

List of Figures

Figure 1: Asia-Pacific biotechnology industry value: $ million, 2014-18

Figure 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2018

Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2018

Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2018-23

Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2018

Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2018

Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2018

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2018

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2018

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2018

Additional Details

Publisher

Marketline

Publisher Information

Reference

260962 |

Number of Pages

39

Report Format

PDF

Marketline Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review provides you...
24 Nov 2015 by Global Data USD $125 More Info
Puma Biotechnology, Inc. (PBYI) - Financial and Strategic SWOT Analysis Review
SummaryPuma Biotechnology, Inc. (Puma) is a biopharmaceutical company that develops and markets ther...
08 Nov 2015 by Global Data USD $300 More Info
Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review
SummaryPrana Biotechnology Limited (Prana Biotech) is a pharmaceutical company that develops therape...
08 Nov 2015 by Global Data USD $300 More Info
Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic SWOT Analysis Review
SummaryGenovate Biotechnology Co., Ltd. (GBL) is a pharmaceutical company that offers formulations. ...
08 Nov 2015 by Global Data USD $300 More Info
Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review
SummaryTamir Biotechnology, Inc. (formerly known as Alfacell Corporation) is a biopharmaceutical com...
08 Nov 2015 by Global Data USD $300 More Info
Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review
SummaryLevel Biotechnology Inc. (LBI) is a biotechnology company that offers molecular biology produ...
08 Nov 2015 by Global Data USD $300 More Info
G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis Review
SummaryG&E Herbal Biotechnology Co., Ltd. (G&E Herbal) is a biopharmaceutical company that offers re...
08 Nov 2015 by Global Data USD $300 More Info
Anhui Anke Biotechnology (Group) Co., Ltd. (300009) - Financial and Strategic SWOT Analysis Review
SummaryAnhui Anke Biotechnology (Group) Co., Ltd. (AnkeBio) is a biotechnology company that develops...
08 Nov 2015 by Global Data USD $300 More Info
Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review
SummaryGolden Biotechnology Corp. (Golden Biotech) is a biotechnology company that develops drugs. T...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Have expectations been reset for Puma Biotechnology's neratinib in HER2+ breast cancer?
Scope Investors appear to be resetting their expectations for Puma Biotechnology's experimental HER2...
01 May 2015 by FirstWord Pharma USD $695 More Info

This report is published by Marketline

Download Free Report Summary PDF

Biotechnology in Asia-Pacific | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...